Doreen M. Hallman

Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer.

A. Benson, N. Kemeny, H. Hochster, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study.

J. Burke, K. Kolibaba, I. Flinn, 2014, Blood.

First-Line Treatment of Patients With Indolent Non-Hodgkin Lymphoma or Mantle-Cell Lymphoma With Bendamustine Plus Rituximab Versus R-CHOP or R-CVP: Results of the BRIGHT 5-Year Follow-Up Study.

J. Burke, K. Kolibaba, I. Flinn, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.